Justin R. Fallon Professor of Medical Science, Professor of Psychiatry and Human Behavior

Justin Fallon is a Professor of Neuroscience and Co-Director of the Center for the Neurobiology of Cells and Synapses at Brown University.  He also founded Tivorsan Pharmaceuticals, a biotech company dedicated to developing therapies for Muscular Dystrophy and ALS. His original training was in cell biology the University of Pennsylvania.  He then expanded into neurobiology during postdoctoral training at University College London and Stanford.  His work led to the discovery of biglycan, a protein that stabilizes the nerve-muscle synapse and controls a key pathway that can compensate for the underlying defect that causes Duchenne Muscular Dystrophy. Fallon also studies the mechanisms of enduring synaptic plastic and how they are defective, and can be corrected, in neurodevelopmental disorders such as Autism. 

Brown Affiliations

Research Areas